Alaunos Therapeutics (TCRT) Earnings Date & Reports

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

TCRT is expected to report earnings to rise 1,025.00% to -44 cents per share on March 05

Alaunos Therapeutics TCRT Stock Earnings Reports

Q4'23

Est.

$-0.45

Q3'23

Est.

$-0.04

Q2'23

Est.

$-0.04

Q1'23

Est.

$-0.04

Q4'22

Beat

by $0.01

The last earnings report on November 14 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 6.36M shares outstanding, the current market capitalization sits at 6.61M.

View a ticker or compare two or three

Compare

TCRT